… tumor. Approximately 5% of patients with breast cancer have clinically detectable metastases
at … to 40% of patients who appear clinically free of metastases harbor occult metastases.3, 4 …

… metastatic breast cancer for levels of circulating tumor cells both before the patients were
to start a new line of treatment and at the first follow-up visit. The progression of the disease or …

… women who died of metastatic breast cancer and on whom an … disease progression in breast
cancer, for which there are significant treatment implications. Patients with bone metastases …

… because it represents an in vivo opportunity to dissect the process responsible for incurable
metastatic disease, that is, the conversion of indolent micrometastases into overt clinically …

… on recent advances on metastatic breast cancer. Detection, … Distant metastases are an
incurable disease and systemic … is to summarise some recent progress in metastatic disease. …

… We provide evidence that disease progression in patients with metastatic breast cancer
in a real-world registry has a significant negative impact on HRQoL as measured by MID of …

… in metastatic breast cancer. The objective of this research was to document and model the
relationship between time-to-disease progression and OS in metastatic breast cancer studies …

… at the time of disease progression. Patients from … disease progression. This report details
the experience of the patients treated with trastuzumab for progressive metastatic breast cancer…

… tumor response, disease control, progression-free survival (PFS), or time to progression (TTP…
for OS to assess the benefits of first-line therapies for patients with metastatic breast cancer. …

… This article reviews the types of breast cancer and cancer … subtypes of breast cancer, symptoms
of metastatic breast cancer, … the prognosis for women with triple-negative breast cancers. …